Kevin Raidy is the Managing Partner of Cowen Healthcare Investments. He is currently a member of the Board of Directors for several biotechnology companies including Aro Biotherapeutics and Orchard Therapeutics. Prior to his role at Cowen Healthcare Investments, Kevin was Cowen’s Head of Investment Banking and previously served as managing director at Cowen Investment Management, where he was portfolio manager for direct investments and convertible bonds. Mr. Raidy's sell-side experience includes ten years at Shipley Raidy Capital Partners LP, a boutique investment banking firm that he co-founded, where he was responsible for sourcing, evaluating, and structuring numerous debt and equity financings and performed M&A advisory services. Prior to founding Shipley Raidy, Kevin was an associate at Philadelphia First Group. He started his career at Cantor Fitzgerald before moving to Merrill Lynch as an analyst in the municipal finance group. Kevin holds a BS in Economics with a concentration in finance from the Wharton School of the University of Pennsylvania.